What is Succinic semialdehyde dehydrogenase deficiency

Succinic semialdehyde dehydrogenase deficiency (SSADH deficiency) is a rare inherited metabolic disorder that impairs the breakdown of gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter in the brain. This leads to the accumulation of toxic substances in the central nervous system, resulting in a spectrum of neurological symptoms including developmental delay, intellectual disability, and seizure disorders.

What causes Succinic semialdehyde dehydrogenase deficiency?

Succinic semialdehyde dehydrogenase deficiency is caused by mutations in the ALDH5A1 gene. This gene provides instructions for making the enzyme succinic semialdehyde dehydrogenase, which is responsible for the final step in the degradation of GABA. When this enzyme is missing or dysfunctional, succinic semialdehyde (SSA) and 4-hydroxybutyric acid (GHB) accumulate in the brain and bodily fluids. This chemical imbalance disrupts normal brain signaling, which is the primary mechanism behind the clinical manifestations of Succinic semialdehyde dehydrogenase deficiency.

How does Succinic semialdehyde dehydrogenase deficiency affect the body?

Because the accumulation of these metabolites primarily affects the central nervous system, the clinical presentation is largely neurological. While the condition is systemic in its metabolic impact, the symptoms are most visible in developmental and cognitive areas. Common features of Succinic semialdehyde dehydrogenase deficiency include:

• Global developmental delay, particularly in speech and language acquisition.


• Hypotonia (low muscle tone) in infancy, which often progresses to ataxia (lack of muscle coordination) in childhood.


• Seizure disorders, which affect approximately 50-60% of patients.


• Behavioral challenges, including ADHD, obsessive-compulsive behaviors, and sleep disturbances.


• Intellectual disability ranging from mild to severe.

How rare is Succinic semialdehyde dehydrogenase deficiency?

Succinic semialdehyde dehydrogenase deficiency is an ultra-rare disorder. While the exact global prevalence is difficult to determine due to underdiagnosis, it is estimated that there are fewer than 500 cases reported in medical literature worldwide. The condition is inherited in an autosomal recessive pattern, meaning both parents must carry a mutation in the ALDH5A1 gene for a child to be affected. At DiseaseMaps.org, 13 people with Succinic semialdehyde dehydrogenase deficiency have already joined our community, providing a vital network for families navigating this rare diagnosis.

What differentiates this condition from other disorders?

It is easy to confuse Succinic semialdehyde dehydrogenase deficiency with other metabolic or neurological conditions due to overlapping symptoms. However, it is distinct due to the specific biochemical profile—specifically, the presence of elevated 4-hydroxybutyric acid in urine and cerebrospinal fluid. Unlike many other neurometabolic disorders, the symptoms of Succinic semialdehyde dehydrogenase deficiency are often chronic rather than progressive, meaning they do not necessarily worsen significantly over time, though they require lifelong management.

Next steps

• Consult a metabolic specialist or a pediatric neurologist to confirm diagnosis via urine organic acid analysis and genetic testing.


• Connect with the 13 members of the DiseaseMaps.org community to share experiences and coping strategies.


• Work with a multidisciplinary team, including speech therapists, physical therapists, and occupational therapists, to manage daily developmental needs.


• Monitor for seizures and behavioral changes, ensuring they are addressed by specialists familiar with the specific metabolic nature of this disorder.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Succinic semialdehyde dehydrogenase deficiency


• Orphanet: Succinic semialdehyde dehydrogenase deficiency (ORPHA:3197)


• OMIM (Online Mendelian Inheritance in Man): ALDH5A1 gene and SSADH deficiency (#271980)


• Journal of Inherited Metabolic Disease: Clinical and biochemical characteristics of SSADH deficiency